Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).
Clinical trial NCT07624799 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07624799
- Sponsor
- French Innovative Leukemia Organisation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-09-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.